60 related articles for article (PubMed ID: 10899226)
1. Dopamine D(1) agonist activates temporal lobe structures in primates.
Black KJ; Hershey T; Gado MH; Perlmutter JS
J Neurophysiol; 2000 Jul; 84(1):549-57. PubMed ID: 10899226
[TBL] [Abstract][Full Text] [Related]
2. Dopa-induced blood flow responses in nonhuman primates.
Hershey T; Black KJ; Carl JL; Perlmutter JS
Exp Neurol; 2000 Dec; 166(2):342-9. PubMed ID: 11085899
[TBL] [Abstract][Full Text] [Related]
3. A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.
Black KJ; Hershey T; Koller JM; Videen TO; Mintun MA; Price JL; Perlmutter JS
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17113-8. PubMed ID: 12482941
[TBL] [Abstract][Full Text] [Related]
4. The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain.
Finnema SJ; Bang-Andersen B; Jørgensen M; Christoffersen CT; Gulyás B; Wikström HV; Farde L; Halldin C
Synapse; 2013 Sep; 67(9):586-95. PubMed ID: 23504964
[TBL] [Abstract][Full Text] [Related]
5. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
Heidenreich BA; Mailman RB; Nichols DE; Napier TC
J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dopamine D1 and D2 receptor function in socially housed cynomolgus monkeys self-administering cocaine.
Czoty PW; Morgan D; Shannon EE; Gage HD; Nader MA
Psychopharmacology (Berl); 2004 Jul; 174(3):381-8. PubMed ID: 14767632
[TBL] [Abstract][Full Text] [Related]
7. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
10. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
11. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
Devous MD; Trivedi MH; Rush AJ
J Nucl Med; 2001 Apr; 42(4):535-42. PubMed ID: 11337538
[TBL] [Abstract][Full Text] [Related]
12. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia.
Mu Q; Johnson K; Morgan PS; Grenesko EL; Molnar CE; Anderson B; Nahas Z; Kozel FA; Kose S; Knable M; Fernandes P; Nichols DE; Mailman RB; George MS
Schizophr Res; 2007 Aug; 94(1-3):332-41. PubMed ID: 17596915
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats.
Desai RI; Neumeyer JL; Bergman J; Paronis CA
Behav Pharmacol; 2007 Dec; 18(8):745-54. PubMed ID: 17989512
[TBL] [Abstract][Full Text] [Related]
14. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
Meschler JP; Clarkson FA; Mathews PJ; Howlett AC; Madras BK
J Pharmacol Exp Ther; 2000 Mar; 292(3):952-9. PubMed ID: 10688609
[TBL] [Abstract][Full Text] [Related]
15. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats.
Haberny SL; Carr KD
Brain Res Mol Brain Res; 2005 Nov; 141(2):121-7. PubMed ID: 16257473
[TBL] [Abstract][Full Text] [Related]
16. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats.
Alleweireldt AT; Weber SM; Kirschner KF; Bullock BL; Neisewander JL
Psychopharmacology (Berl); 2002 Jan; 159(3):284-93. PubMed ID: 11862361
[TBL] [Abstract][Full Text] [Related]
17. [The mechanism of controlling regional cerebral blood flow in patients with localization-related epilepsy].
Katayama S; Momose T; Sano I; Nakashima Y; Nakajima T; Niwa S; Matsushita M
Seishin Shinkeigaku Zasshi; 1996; 98(2):89-114. PubMed ID: 8935829
[TBL] [Abstract][Full Text] [Related]
18. Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats.
Taymans JM; Kia HK; Groenewegen HJ; Leysen JE; Langlois X
Neuroscience; 2005; 134(2):643-56. PubMed ID: 15964700
[TBL] [Abstract][Full Text] [Related]
19. Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
Blanchet PJ; Grondin R; Bédard PJ
Mov Disord; 1996 Jan; 11(1):91-4. PubMed ID: 8771074
[TBL] [Abstract][Full Text] [Related]
20. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
